TrialPanorama/TrialPanorama-database huggingface dataset:
Study 22073145 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 22073145 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 22073145 — Predictive Biomarker (PRD): CRHR1 mRNA
Genes: CRHR1; CRFR; CRFR1; CRHR
Study 22075481 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 22076476 — Predictive Biomarker (PRD): Hormone receptor
Study 22078984 — Surrogate Endpoint (SUR): Blood pressure
Study 22079961 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 22080223 — Surrogate Endpoint (SUR): Blood pressure
Study 22080838 — Predictive Biomarker (PRD): CHRNA3 mRNA
Genes: CHRNA3; NACHRA3
Study 22080838 — Predictive Biomarker (PRD): CHRNA5 mRNA
Genes: CHRNA5; NACHRA5
Study 22080838 — Predictive Biomarker (PRD): HHIP mRNA
Genes: HHIP; HIP; UNQ5825/PRO19644
Study 22080838 — Predictive Biomarker (PRD): FAM13A mRNA
Genes: FAM13A; FAM13A1; KIAA0914
Study 22080838 — Predictive Biomarker (PRD): RAB4B mRNA
Genes: RAB4B; PP1596
Study 22080838 — Predictive Biomarker (PRD): EGLN2 mRNA
Genes: EGLN2; EIT6
Study 22080838 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study 22080838 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 22081446 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 22082029 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22082029 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 22082029 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 22086881 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 22086881 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 22088989 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 22088989 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 22090362 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 22092012 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 22093206 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 22094934 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22095114 — Predictive Biomarker (PRD): SDCCAG8 mRNA
Genes: SDCCAG8; CCCAP; NPHP10; HSPC085
Study 22095114 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study 22095114 — Predictive Biomarker (PRD): TNKS mRNA
Genes: TNKS; PARP5A; PARPL; TIN1; TINF1; TNKS1
Study 22096242 — Surrogate Endpoint (SUR): Blood pressure
Study 22098110 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 22106236 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 22106236 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 22110211 — Predictive Biomarker (PRD): PLN mRNA
Genes: PLN; PLB
Study 22118987 — Predictive Biomarker (PRD): LRIT1 mRNA
Genes: LRIT1; LRRC21; PAL
Study 22127692 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 22127692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22127697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22127697 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 22127697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22127697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22127697 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22127697 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 22127844 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 22127927 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22129044 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22129044 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22129253 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22129253 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 22129253 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22129252 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22129252 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 22129252 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22131611 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22134145 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22137491 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 22137663 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 22145021 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 22145021 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study 22145984 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 22147712 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 22152120 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 22152427 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22152427 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 22153792 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22155140 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22155453 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 22157326 — Surrogate Endpoint (SUR): Blood pressure
Study 22160069 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 22160298 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22160384 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 22160384 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22163120 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22165955 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22165955 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22169111 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 22169111 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 22170723 — Surrogate Endpoint (SUR): Serum triglycerides
Study 22171692 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 22171697 — Surrogate Endpoint (SUR): Pathological complete response
Study 22172590 — Surrogate Endpoint (SUR): Blood pressure
Study 22173060 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 22174351 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 22174752 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 22174752 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22174752 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 22176869 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22180164 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22180427 — Predictive Biomarker (PRD): Liver iron
Study 22184407 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study 22184407 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 22188558 — Surrogate Endpoint (SUR): Serum testosterone
Study 22190676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22197613 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22197613 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 22197613 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22198152 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22198152 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 22198152 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 22198152 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 22198310 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 22198310 — Predictive Biomarker (PRD): ELANE mRNA
Genes: ELANE; ELA2
Study 22198310 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 22198310 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 22198309 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22198412 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22198412 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22203761 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22203761 — Predictive Biomarker (PRD): CD63 mRNA
Genes: CD63; MLA1; TSPAN30
Study 22206353 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 22206473 — Surrogate Endpoint (SUR): Blood pressure
Study 22206727 — Monitoring Biomarker (MOI): Procalcitonin
Study 22210086 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22210086 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 22210091 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 22210091 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22210091 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 22211928 — Surrogate Endpoint (SUR): Blood pressure
Study 22212516 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22212857 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 22212936 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22217879 — Surrogate Endpoint (SUR): Blood pressure
Study 22219223 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22221511 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22221511 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22221511 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 22222175 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 22233350 — Monitoring Biomarker (MOI): HBV DNA
Study 22233865 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 22233865 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 22233865 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22234149 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 22235243 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 22235252 — Surrogate Endpoint (SUR): Bone mineral density
Study 22244041 — Surrogate Endpoint (SUR): Blood pressure
Study 22246178 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 22246178 — Safety Biomarker (SAF): Reactive oxygen species
Study 22247754 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 22248486 — Surrogate Endpoint (SUR): Bone mineral density
Study 22248721 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22249355 — Predictive Biomarker (PRD): CRHR1 mRNA
Genes: CRHR1; CRFR; CRFR1; CRHR
Study 22249355 — Predictive Biomarker (PRD): NR3C1 mRNA
Genes: NR3C1; GRL
Study 22249355 — Predictive Biomarker (PRD): PDE1A mRNA
Genes: PDE1A
Study 22249355 — Safety Biomarker (SAF): DRD3
Study 22249355 — Predictive Biomarker (PRD): PDE1A
Study 22249367 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 22249430 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 22250979 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22253412 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22253412 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22253485 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 22253485 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 22253485 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22256804 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study 22256804 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 22256804 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 22256804 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 22256804 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 22258485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22260199 — Surrogate Endpoint (SUR): Blood pressure
Study 22261507 — Surrogate Endpoint (SUR): Blood pressure
Study 22263035 — Predictive Biomarker (PRD): CENPJ mRNA
Genes: CENPJ; CPAP; LAP; LIP1
Study 22263047 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 22264765 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 22264765 — Predictive Biomarker (PRD): CXCR5 mRNA
Genes: CXCR5; BLR1; MDR15
Study 22264765 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 22264850 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22264850 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22265115 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 22267606 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22267607 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22267687 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 22267750 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22270258 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 22270330 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22270330 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 22270480 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22272830 — Predictive Biomarker (PRD): XRCC3 mRNA
Genes: XRCC3
Study 22272830 — Predictive Biomarker (PRD): RAD51 mRNA
Genes: RAD51; RAD51A; RECA
Study 22272830 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study 22275401 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 22275401 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22276954 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 22277685 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22280813 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 22281249 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 22281388 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 22281797 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 22281831 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22281831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22282683 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22282683 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22282683 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 22283499 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22283499 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 22284935 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 22285199 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 22285963 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 22289893 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 22292502 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22292600 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 22293175 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 22293175 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 22293660 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 22294344 — Safety Biomarker (SAF): Interleukin 1
Study 22294344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22294344 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 22296955 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22302349 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 22302662 — Monitoring Biomarker (MOI): Procalcitonin
Study 22304793 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22306782 — Surrogate Endpoint (SUR): Blood pressure
Study 22308041 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22308288 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 22308288 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 22308295 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 22308295 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 22312169 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22314007 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 22315486 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 22316363 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 22316363 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 22318219 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 22318219 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22318219 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 22325048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22325048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22325068 — Surrogate Endpoint (SUR): Blood pressure
Study 22325357 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22325357 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22325452 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22325452 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22326922 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22326924 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 22326924 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 22328334 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 22329763 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study 22329763 — Surrogate Endpoint (SUR): Blood pressure
Study 22331380 — Surrogate Endpoint (SUR): Blood pressure
Study 22335424 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 22339949 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 22339949 — Safety Biomarker (SAF): BDNF
Study 22340331 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22340331 — Surrogate Endpoint (SUR): Blood pressure
Study 22342553 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22343511 — Monitoring Biomarker (MOI): HBV DNA
Study 22343727 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 22344775 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study 22344775 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22345427 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 22345427 — Predictive Biomarker (PRD): ATG12 mRNA
Genes: ATG12; APG12; APG12L
Study 22345427 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study 22345427 — Predictive Biomarker (PRD): DNM1L mRNA
Genes: DNM1L; DLP1; DRP1
Study 22345427 — Predictive Biomarker (PRD): PINK1 mRNA
Genes: PINK1
Study 22345427 — Predictive Biomarker (PRD): FOXO3 mRNA
Genes: FOXO3; FKHRL1; FOXO3A
Study 22347360 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22347526 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 22347526 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22348003 — Predictive Biomarker (PRD): CD83 mRNA
Genes: CD83
Study 22348003 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 22348003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22348003 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 22348003 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 22353806 — Predictive Biomarker (PRD): FMN1 mRNA
Genes: FMN1; FMN; LD